<DOC>
	<DOC>NCT01568424</DOC>
	<brief_summary>The study objective is to gather post-market clinical data on the use of the CentriMag RVAS when used for temporary mechanical circulatory support of the right ventricle in patients with acute right ventricular failure from any cause</brief_summary>
	<brief_title>CentriMag RVAS U.S. Post-approval Study Protocol</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Right ventricular failure from any cause Primary coagulopathy or platelet disorders Allergy or sensitivity to heparin and all alternative anticoagulants</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Right Ventricular Failure</keyword>
	<keyword>Levitronix</keyword>
</DOC>